New Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti Tumor Activity of VB 111 in Recurrent GBM

Press/Media: Press / Media

PeriodJun 5 2017

Media coverage

1

Media coverage

  • TitleNew Phase 2 Patient Data Presented at ASCO Strengthen the Evidence for Anti Tumor Activity of VB 111 in Recurrent GBM
    Media name/outletMarket News Publishing
    CountryUnited States
    Date6/5/17
    PersonsAndrew Brenner